Remarkably, CCL4/MIP-1β plasma concentrations were significantly higher among patients with arthritis than in non-arthritic patients [(HD 242 (203–301), without arthritis 244 (81–495), with arthritis 435 (273–994) median and interquartile range (IQR)] (Figure 6c). Here, CCL4 is linked to arthritic joint disease.